These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19901191)

  • 21. Lipidation of apolipoprotein A-I by ATP-binding cassette transporter (ABC) A1 generates an interaction partner for ABCG1 but not for scavenger receptor BI.
    Lorenzi I; von Eckardstein A; Radosavljevic S; Rohrer L
    Biochim Biophys Acta; 2008; 1781(6-7):306-13. PubMed ID: 18485926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reconstituted high-density lipoprotein infusion modulates fatty acid metabolism in patients with type 2 diabetes mellitus.
    Drew BG; Carey AL; Natoli AK; Formosa MF; Vizi D; Reddy-Luthmoodoo M; Weir JM; Barlow CK; van Hall G; Meikle PJ; Duffy SJ; Kingwell BA
    J Lipid Res; 2011 Mar; 52(3):572-81. PubMed ID: 21224289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ApoA-1 infusion reduces arterial cholesterol and myocardial lesions in a rat model of cardiac dysfunction and insulin resistance.
    Borthwick F; Warnakula S; Mangat R; Uwiera RR; Russell JC; Kelly SE; Lee CY; Hryshko L; Mamo JC; Rye KA; Lopaschuk GD; Proctor SD
    Atherosclerosis; 2012 Jun; 222(2):402-8. PubMed ID: 22483015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adipocyte modulation of high-density lipoprotein cholesterol.
    Zhang Y; McGillicuddy FC; Hinkle CC; O'Neill S; Glick JM; Rothblat GH; Reilly MP
    Circulation; 2010 Mar; 121(11):1347-55. PubMed ID: 20212278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
    Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
    Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of reconstituted high-density lipoprotein on coagulation, fibrinolysis and platelet activation during human endotoxemia.
    Pajkrt D; Lerch PG; van der Poll T; Levi M; Illi M; Doran JE; Arnet B; van den Ende A; ten Cate JW; van Deventer SJ
    Thromb Haemost; 1997 Feb; 77(2):303-7. PubMed ID: 9157586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adiponectin increases macrophages cholesterol efflux and suppresses foam cell formation in patients with type 2 diabetes mellitus.
    Wang M; Wang D; Zhang Y; Wang X; Liu Y; Xia M
    Atherosclerosis; 2013 Jul; 229(1):62-70. PubMed ID: 23466101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel formulation of a reconstituted high-density lipoprotein (CSL112) dramatically enhances ABCA1-dependent cholesterol efflux.
    Diditchenko S; Gille A; Pragst I; Stadler D; Waelchli M; Hamilton R; Leis A; Wright SD
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2202-11. PubMed ID: 23868939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-density lipoprotein reduces the human monocyte inflammatory response.
    Murphy AJ; Woollard KJ; Hoang A; Mukhamedova N; Stirzaker RA; McCormick SP; Remaley AT; Sviridov D; Chin-Dusting J
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2071-7. PubMed ID: 18617650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque.
    Shaw JA; Bobik A; Murphy A; Kanellakis P; Blombery P; Mukhamedova N; Woollard K; Lyon S; Sviridov D; Dart AM
    Circ Res; 2008 Nov; 103(10):1084-91. PubMed ID: 18832751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergetic Effect of rHDL and LXR Agonist on Reduction of Atherosclerosis in Mice.
    Morin EE; Guo Y; He H; Yuan W; Souery WN; Fawaz MV; Chen YE; Schwendeman A
    Front Pharmacol; 2020; 11():513031. PubMed ID: 33390931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic applications of reconstituted HDL: When structure meets function.
    Darabi M; Guillas-Baudouin I; Le Goff W; Chapman MJ; Kontush A
    Pharmacol Ther; 2016 Jan; 157():28-42. PubMed ID: 26546991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin.
    Watala C; Pluta J; Golanski J; Rozalski M; Czyz M; Trojanowski Z; Drzewoski J
    J Mol Med (Berl); 2005 Feb; 83(2):148-58. PubMed ID: 15723265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins.
    Wang N; Lan D; Chen W; Matsuura F; Tall AR
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9774-9. PubMed ID: 15210959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HDL scavenger receptor class B type I and platelet function.
    Nofer JR; van Eck M
    Curr Opin Lipidol; 2011 Aug; 22(4):277-82. PubMed ID: 21537173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia.
    Pajkrt D; Doran JE; Koster F; Lerch PG; Arnet B; van der Poll T; ten Cate JW; van Deventer SJ
    J Exp Med; 1996 Nov; 184(5):1601-8. PubMed ID: 8920850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of low-dose EPA-E on glycemic control, lipid profile, lipoprotein(a), platelet aggregation, viscosity, and platelet and vessel wall interaction in NIDDM.
    Westerveld HT; de Graaf JC; van Breugel HH; Akkerman JW; Sixma JJ; Erkelens DW; Banga JD
    Diabetes Care; 1993 May; 16(5):683-8. PubMed ID: 8495604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 15-Lipoxygenase-mediated modification of high-density lipoproteins impairs SR-BI- and ABCA1-dependent cholesterol efflux from macrophages.
    Pirillo A; Uboldi P; Kuhn H; Catapano AL
    Biochim Biophys Acta; 2006 Mar; 1761(3):292-300. PubMed ID: 16647293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease.
    Capodanno D; Patel A; Dharmashankar K; Ferreiro JL; Ueno M; Kodali M; Tomasello SD; Capranzano P; Seecheran N; Darlington A; Tello-Montoliu A; Desai B; Bass TA; Angiolillo DJ
    Circ Cardiovasc Interv; 2011 Apr; 4(2):180-7. PubMed ID: 21386092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice.
    Chroni A; Kan HY; Kypreos KE; Gorshkova IN; Shkodrani A; Zannis VI
    Biochemistry; 2004 Aug; 43(32):10442-57. PubMed ID: 15301543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.